MPH Health Care AG Asset Resilience Ratio
MPH Health Care AG asset resilience ratio. MPH Health Care AG (93M1) has an Asset Resilience Ratio of 0.17% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of MPH Health Care AG to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of MPH Health Care AG (2016–2025)
Asset resilience ratio of MPH Health Care AG from 2016 to 2025. This chart shows how MPH Health Care AG's Asset Resilience Ratio has changed over time. Read 93M1 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down MPH Health Care AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 93M1 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €435.17K | 0.17% |
| Total Liquid Assets | €435.17K | 0.17% |
Asset Resilience Insights
- Limited Liquidity: MPH Health Care AG maintains only 0.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
MPH Health Care AG Industry Peers by Asset Resilience Ratio
Compare MPH Health Care AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sherborne Investors Guernsey C Ltd
LSE:SIGC |
Asset Management | 4.26% |
|
Julius Baer Gruppe AG
SW:BAER |
Asset Management | 15.49% |
|
Caitong Securities Co Ltd
SHG:601108 |
Asset Management | 13.57% |
|
Argo Investments Ltd
AU:ARG |
Asset Management | 0.46% |
|
Anxin Trust Co Ltd
SHG:600816 |
Asset Management | 36.21% |
|
Investco Holding AS
IS:INVES |
Asset Management | 11.35% |
|
Shaanxi International Trust Co Ltd
SHE:000563 |
Asset Management | 12.83% |
|
A.F.P. Habitat
SN:HABITAT |
Asset Management | 7.59% |
MPH Health Care AG Asset Resilience Ratio by Year (2016–2025)
MPH Health Care AG asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for MPH Health Care AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.17% | €435.17K ≈ $508.76K |
€258.09 Million ≈ $301.73 Million |
+0.11pp |
| 2024-12-31 | 0.06% | €164.77K ≈ $192.64K |
€291.06 Million ≈ $340.28 Million |
-0.15pp |
| 2023-12-31 | 0.20% | €543.22K ≈ $635.08K |
€266.35 Million ≈ $311.39 Million |
-0.70pp |
| 2022-12-31 | 0.91% | €2.15 Million ≈ $2.51 Million |
€236.99 Million ≈ $277.07 Million |
-0.41pp |
| 2021-12-31 | 1.31% | €2.60 Million ≈ $3.04 Million |
€198.00 Million ≈ $231.48 Million |
-0.52pp |
| 2020-12-31 | 1.83% | €3.86 Million ≈ $4.52 Million |
€210.71 Million ≈ $246.34 Million |
+1.73pp |
| 2019-12-31 | 0.10% | €305.04K ≈ $356.62K |
€293.14 Million ≈ $342.72 Million |
+0.08pp |
| 2018-12-31 | 0.02% | €64.23K ≈ $75.10K |
€286.25 Million ≈ $334.66 Million |
-2.12pp |
| 2017-12-31 | 2.14% | €5.52 Million ≈ $6.45 Million |
€257.38 Million ≈ $300.90 Million |
-1.97pp |
| 2016-12-31 | 4.11% | €9.47 Million ≈ $11.07 Million |
€230.33 Million ≈ $269.28 Million |
-- |
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology… Read more